Skip to content

Clinical trials

Dementia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Country / region: Russia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20071
20134
20142
20162
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.3
AstraZeneca2
Novartis Pharmaceuticals2
TauRx Therapeutics Ltd2
Eisai Co., Ltd.1
Hoffmann-La Roche1
Istituto Auxologico Italiano1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia12
Alzheimer Disease10
Cognitive Dysfunction5
Mental Disorders5
Nervous System Diseases5
Brain Diseases4
Neurodegenerative Diseases4
Psychomotor Agitation3
Central Nervous System Diseases2
Tauopathies2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.